Your browser doesn't support javascript.
loading
Efficacy of infliximab in the treatment of Erdheim-Chester disease.
Cohen-Aubart, Fleur; Maksud, Philippe; Emile, Jean-François; Benameur, Neila; Charlotte, Frédéric; Cluzel, Philippe; Amoura, Zahir; Haroche, Julien.
Afiliação
  • Cohen-Aubart F; Internal Medicine Department 2, AP-HP, French National Reference Centre for Rare Systemic Diseases, Pitié-Salpêtrière Hospital, Paris, France.
  • Maksud P; Paris VI University, UPMC, Sorbonne Universités, Paris, France.
  • Emile JF; Paris VI University, UPMC, Sorbonne Universités, Paris, France.
  • Benameur N; Nuclear Medicine Department, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Charlotte F; Pathology Department, AP-HP, Ambroise Paré Hospital, Versailles University, Boulogne, France.
  • Cluzel P; Pharmacy Department, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Amoura Z; Paris VI University, UPMC, Sorbonne Universités, Paris, France.
  • Haroche J; Pathology Department, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
Ann Rheum Dis ; 77(9): 1387-1390, 2018 09.
Article em En | MEDLINE | ID: mdl-29363511
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antirreumáticos / Doença de Erdheim-Chester / Infliximab Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antirreumáticos / Doença de Erdheim-Chester / Infliximab Idioma: En Ano de publicação: 2018 Tipo de documento: Article